PFE Pfizer Inc

Price (delayed)

$51.78

Market cap

$290.66B

P/E Ratio

9.75

Dividend/share

$1.6

EPS

$5.31

Enterprise value

$326.03B

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights
Pfizer's net income has surged by 53% YoY
Pfizer's EPS has soared by 53% YoY

Key stats

What are the main financial stats of PFE
Market
Shares outstanding
5.61B
Market cap
$290.66B
Enterprise value
$326.03B
Valuations
Price to earnings (P/E)
9.75
Price to book (P/B)
3.14
Price to sales (P/S)
2.91
EV/EBIT
9.82
EV/EBITDA
8.57
EV/Sales
3.27
Earnings
Revenue
$99.68B
EBIT
$33.2B
EBITDA
$38.03B
Free cash flow
$23.37B
Per share
EPS
$5.31
Free cash flow per share
$4.17
Book value per share
$16.5
Revenue per share
$17.78
TBVPS
$21
Balance sheet
Total assets
$195.35B
Total liabilities
$102.46B
Debt
$36.67B
Equity
$92.63B
Working capital
$26.09B
Liquidity
Debt to equity
0.4
Current ratio
1.59
Quick ratio
1.18
Net debt/EBITDA
0.93
Margins
EBITDA margin
38.1%
Gross margin
65.6%
Net margin
29.9%
Operating margin
33.8%
Efficiency
Return on assets
15.8%
Return on equity
35.1%
Return on invested capital
32%
Return on capital employed
22%
Return on sales
33.3%
Dividend
Dividend yield
3.09%
DPS
$1.6
Payout ratio
30.1%

PFE stock price

How has the Pfizer stock price performed over time
Intraday
3.07%
1 week
1.37%
1 month
9.36%
1 year
0.74%
YTD
-12.31%
QTD
18.33%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$99.68B
Gross profit
$65.39B
Operating income
$33.68B
Net income
$29.77B
Gross margin
65.6%
Net margin
29.9%
The operating income has soared by 60% YoY and by 3.6% from the previous quarter
Pfizer's net income has surged by 53% YoY
Pfizer's revenue has increased by 45% YoY
Pfizer's gross profit has increased by 45% YoY and by 3.9% from the previous quarter

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
P/E
9.75
P/B
3.14
P/S
2.91
EV/EBIT
9.82
EV/EBITDA
8.57
EV/Sales
3.27
Pfizer's EPS has soared by 53% YoY
The price to earnings (P/E) is 36% lower than the 5-year quarterly average of 14.8 and 16% lower than the last 4 quarters average of 11.2
Pfizer's equity has increased by 22% YoY and by 6% QoQ
PFE's P/B is 13% below its last 4 quarters average of 3.5 and 8% below its 5-year quarterly average of 3.3
Pfizer's revenue has increased by 45% YoY
PFE's P/S is 37% below its 5-year quarterly average of 4.5 and 9% below its last 4 quarters average of 3.1

Efficiency

How efficient is Pfizer business performance
The company's return on invested capital rose by 43% YoY
Pfizer's ROA has increased by 35% YoY
The ROE rose by 25% YoY but it fell by 3.3% QoQ
Pfizer's ROS has increased by 10% YoY and by 5% from the previous quarter

Dividends

What is PFE's dividend history
DPS
$1.6
Dividend yield
3.09%
Payout ratio
30.1%
Recent dividends

Financial health

How did Pfizer financials performed over time
PFE's total assets is 91% greater than its total liabilities
The quick ratio has grown by 19% YoY and by 16% from the previous quarter
The current ratio has grown by 14% YoY and by 12% from the previous quarter
PFE's debt is 60% less than its equity
The debt to equity has contracted by 25% YoY and by 13% from the previous quarter
Pfizer's equity has increased by 22% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.